Designing and repurposing drugs to target intrinsically disordered proteins for cancer treatment: using NUPR1 as a paradigm

Authors Santofimia-Castaño P, Rizzuti B, Xia Y, Abian O,,,,, Peng L, Velázquez-Campoy A,,,,, Iovanna JL, Neira JL,
Details Mol Cell Oncol. 2019 May 16;6(5):e1612678. doi: 10.1080/23723556.2019.1612678. eCollection 2019
DOI 10.1080/23723556.2019.1612678
Source View on PubMed

Join the conversation

Create an Account or Sign In to comment.